In Pursuit of Innovation Excellence: Re-imagining the CardioMetabolic Research Landscape
Our track record of excellence in research and landmark clinical trials in CardioMetabolic diseases is evidence of our innovation which has resulted in important breakthroughs in recent years, especially in thromboembolic diseases and type 2 diabetes. The teams at our dedicated research centers in Germany and the USA are now looking to re-shape the cardiometabolic research landscape. They are working with many academic and industry partners to discover and develop the breakthrough treatments of the future that will continue our legacy of innovation in CardioMetabolic disease research.
We have been able to help many millions of patients as a result of the success in cardiometabolic disease research. But now we’re looking to the next wave of innovation. Our holistic approach gives us the opportunity to take a broad perspective and explore a number of different research fields, allowing us to prioritize the most promising avenues of discovery and create synergies across our research programs. This wide-ranging approach may yield complementary mechanisms of action which could result in therapeutic combinations with the potential for improved efficacy and fewer side effects – enabling us to help many more millions of patients around the world.
